1
|
Shvets Y, Khranovska N, Senchylo N, Ostapchenko D, Tymoshenko I, Onysenko S, Kobyliak N, Falalyeyeva T. Microbiota substances modulate dendritic cells activity: A critical view. Heliyon 2024; 10:e27125. [PMID: 38444507 PMCID: PMC10912702 DOI: 10.1016/j.heliyon.2024.e27125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Revised: 02/23/2024] [Accepted: 02/23/2024] [Indexed: 03/07/2024] Open
Abstract
Contemporary research in the field of microbiota shows that commensal bacteria influence physiological activity of different organs and systems of a human organism, such as brain, lungs, immune and metabolic systems. This influence is realized by various processes. One of them is trough modulation of immune mechanisms. Interactions between microbiota and the human immune system are known to be complex and ambiguous. Dendritic cells (DCs) are unique cells, which initiate the development and polarization of adaptive immune response. These cells also interconnect native and specific immune reactivity. A large set of biochemical signals from microbiota in the form of different microbiota associated molecular patterns (MAMPs) and bacterial metabolites that act locally and distantly in the human organism. As a result, commensal bacteria influence the maturity and activity of dendritic cells and affect the overall immune reactivity of the human organism. It then determines the response to pathogenic microorganisms, inflammation, associated with different pathological conditions and even affects the effectiveness of vaccination.
Collapse
Affiliation(s)
- Yuliia Shvets
- Taras Shevchenko National University of Kyiv, 64/13 Volodymyrska Str., Kyiv, Ukraine
| | - Natalia Khranovska
- National Cancer Institute of Ukraine, 33/43 Yuliia Zdanovska Str., Kyiv, Ukraine
| | - Natalia Senchylo
- Taras Shevchenko National University of Kyiv, 64/13 Volodymyrska Str., Kyiv, Ukraine
| | - Danylo Ostapchenko
- Taras Shevchenko National University of Kyiv, 64/13 Volodymyrska Str., Kyiv, Ukraine
| | - Iryna Tymoshenko
- Bogomolets National Medical University, 13 Shevchenka Blvd., Kyiv, Ukraine
| | - Svitlana Onysenko
- Taras Shevchenko National University of Kyiv, 64/13 Volodymyrska Str., Kyiv, Ukraine
| | - Nazarii Kobyliak
- Bogomolets National Medical University, 13 Shevchenka Blvd., Kyiv, Ukraine
- Medical Laboratory CSD, 22b Zhmerynska Str., Kyiv, Ukraine
| | - Tetyana Falalyeyeva
- Taras Shevchenko National University of Kyiv, 64/13 Volodymyrska Str., Kyiv, Ukraine
- Medical Laboratory CSD, 22b Zhmerynska Str., Kyiv, Ukraine
| |
Collapse
|
2
|
Glavatskyi O, Khranovska N, Skachkova O, Gorbach O, Khmelnytskyi H, Shuba I, Pedachenko Y, Zemskova O, Zemskova O. DENDRITIC CELLS IN GLIOBLASTOMA TREATMENT: A MODERN VIEW OF THE PROBLEM AND OWN EXPERIENCE. Exp Oncol 2023; 45:282-296. [PMID: 38186026 DOI: 10.15407/exp-oncology.2023.03.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Indexed: 01/09/2024]
Abstract
Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults. The improvement of the efficacy of GBM treatment is an urgent problem encouraging the development of novel therapeutic strategies, in particular, immunotherapeutic modalities. With more understanding of the intimate interrelationships between the immune system and the mechanisms involved in cancer origin and progression, the skepticism related to the relevance of the immunotherapeutic approaches in the treatment of brain tumors is gradually decreasing. The review discloses the modern concepts on the association between CNS and the immune system. For a long time, CNS was considered as the immunoprivileged site that prevents the effects of immunotherapy in the treatment of brain tumors. Nowadays, these views are reconsidered, which opens the way to the use of immunotherapeutic approaches in GBM treatment. The results of the recent clinical trials on immunotherapy as a supplement to the conventional GBM treatment are considered. Vaccines based on the dendritic cell (DC) technology are regarded as the most promising for this purpose. The preliminary results of the Ukrainian clinical study are also presented and discussed. The results of the international clinical trials as well as our own experience give evidence of the relevance for using DC vaccines in the complex treatment of GBM, which is supported by the increased survival of patients and the safety of vaccine application. It is of high importance that GBM patients with the most unfavorable prognosis can benefit from DC vaccines as a component of the complex treatment. The prospects for immunotherapy in neurooncology are discussed.
Collapse
Affiliation(s)
- O Glavatskyi
- State Institution "Academician Romodanov Institute of Neurosurgery, the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine
| | - N Khranovska
- State Non-commercial Enterprise "National Cancer Institute", Kyiv, Ukraine
| | - O Skachkova
- State Non-commercial Enterprise "National Cancer Institute", Kyiv, Ukraine
| | - O Gorbach
- State Non-commercial Enterprise "National Cancer Institute", Kyiv, Ukraine
| | - H Khmelnytskyi
- State Institution "Academician Romodanov Institute of Neurosurgery, the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine
| | - I Shuba
- State Institution "Academician Romodanov Institute of Neurosurgery, the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine
| | - Ye Pedachenko
- State Institution "Academician Romodanov Institute of Neurosurgery, the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine
| | - O Zemskova
- State Institution "Academician Romodanov Institute of Neurosurgery, the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.
| | - O Zemskova
- State Institution "Academician Romodanov Institute of Neurosurgery, the National Academy of Medical Sciences of Ukraine", Kyiv, Ukraine.
| |
Collapse
|
3
|
Inomistova M, Klymniuk H, Khranovska N, Pavlyk S, Shaida E, Gorbach A, Skachkova O, Shymon D. EXPRESSION OF GENES INVOLVED IN P53 PATHWAY REGULATION IN NEUROBLASTOMA: A SHORT REVIEW. Exp Oncol 2022; 44:266-271. [PMID: 36811541 DOI: 10.32471/exp-oncology.2312-8852.vol-44-no-4.18960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
The search for new prognostic and stratification genetic and epigenetic markers in neuroblastoma is an urgent problem in pediatric oncology. The review summarizes recent progress in studying the expression of genes involved in p53 pathway regulation in neuroblastoma. Several markers associated with recurrence risk and poor outcome are considered. Among them are MYCN amplification, high MDM2 and GSTP1 expression and homozygous mutant allele variant of GSTP1 gene A313G polymorphism. Prognostic criteria for neuroblastoma based on the analysis of miR-34a, miR-137, miR-380-5p, and miR-885-5p expression involved in regulating p53-mediated pathway are also considered. The authors' research data on the role of the above markers in regulation of this pathway in neuroblastoma are presented. The study of alterations in expression of microRNAs and genes involved in p53 pathway regulation will not only expand our understanding of the mechanisms of neuroblastoma pathogenesis but could substantiate new approaches for delineating risk groups and risk stratification of neuroblastoma patients as well as treatment optimization based on the genetic characteristics of the tumor.
Collapse
Affiliation(s)
| | - H Klymniuk
- National Cancer Institute, Kyiv 03022, Ukraine
| | | | - S Pavlyk
- National Cancer Institute, Kyiv 03022, Ukraine
| | - E Shaida
- National Cancer Institute, Kyiv 03022, Ukraine
| | - A Gorbach
- National Cancer Institute, Kyiv 03022, Ukraine
| | - O Skachkova
- National Cancer Institute, Kyiv 03022, Ukraine
| | - D Shymon
- National Cancer Institute, Kyiv 03022, Ukraine
| |
Collapse
|
4
|
Stepanov YV, Golovynska I, Golovynskyi S, Garmanchuk LV, Gorbach O, Stepanova LI, Khranovska N, Ostapchenko LI, Ohulchanskyy TY, Qu J. Red and near infrared light-stimulated angiogenesis mediated via Ca 2+ influx, VEGF production and NO synthesis in endothelial cells in macrophage or malignant environments. J Photochem Photobiol B 2022; 227:112388. [PMID: 35074677 DOI: 10.1016/j.jphotobiol.2022.112388] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/16/2021] [Revised: 01/02/2022] [Accepted: 01/08/2022] [Indexed: 12/19/2022]
Abstract
Irradiation with red or near-infrared (NIR) light in low level light therapy (LLLT) is found to stimulate cellular processes and bioenergetics, resulting in enhanced wound healing, pain control, neurodegenerative diseases treatment, etc. During light irradiation of tissues and organs, different cells are affected, though the connection between photostimulation of cells and their environmental conditions remains poorly understood. In this report, red/NIR light-stimulated angiogenesis is investigated using endothelial cells in vitro, with a focus on the capillary-like structure (CLS) formation and the respective biochemical processes in cells under conditions proximate to a healthy or malignant environment, which strongly defines angiogenesis. To model environmental conditions for endotheliocytes in vitro, the cell culture environment was supplemented by an augmented conditioned medium from macrophages or cancer cells. The biochemical processes in endothelial cell cultures were investigated with and without irradiation by red (650 nm) and near-infrared (808 nm) laser diodes and under normoxia or hypoxia conditions. A light-stimulated angiogenesis has been found, with a more efficient stimulation by 650 nm light compared to 808 nm light. It was shown that the irradiation with light promoted extracellular Ca2+ influx, fostered cell cycle progression, proliferation and NO generation in endothelial cells, and caused an increase in vascular endothelial growth factor (VEGF) production by endothelial cells and M2 macrophages under hypoxia conditions. The activation of VEGF production by macrophages was found to be associated with an increase in the number of M2 macrophages after light irradiation under hypoxia conditions. Thus, a new pathway of an activation of the endothelial cell metabolism, which is related with the extracellular Ca2+ influx after light irradiation, has been revealed. STATEMENT OF SIGNIFICANCE: Red/NIR light-stimulated angiogenesis has been studied using endothelial cells in vitro, with focus on CLS formation and the respective biochemical processes in cell models proximate to a healthy or malignant environment. A light-stimulated angiogenesis has been found, stimulated via extracellular Ca2+ influx, cell cycle progression, proliferation and NO generation, VEGF production increase by endothelial cells under hypoxia conditions.
Collapse
Affiliation(s)
- Yurii V Stepanov
- Center for Biomedical Optics and Photonics, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, PR China
| | - Iuliia Golovynska
- Center for Biomedical Optics and Photonics, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, PR China
| | - Sergii Golovynskyi
- Center for Biomedical Optics and Photonics, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, PR China
| | - Liudmyla V Garmanchuk
- Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - Oleksandr Gorbach
- Laboratory of Experimental Oncology, National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| | - Liudmyla I Stepanova
- Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - Natalia Khranovska
- Laboratory of Experimental Oncology, National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| | - Liudmyla I Ostapchenko
- Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine
| | - Tymish Y Ohulchanskyy
- Center for Biomedical Optics and Photonics, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, PR China.
| | - Junle Qu
- Center for Biomedical Optics and Photonics, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, PR China.
| |
Collapse
|
5
|
Khranovska N, Skachkova O, Gorbach O, Inomistova M, Orel V. Magnetically sensitive nanocomplex enhances antitumor efficacy of dendritic cell-based immunotherapy. Exp Oncol 2021; 43:217-223. [PMID: 34591429 DOI: 10.32471/exp-oncology.2312-8852.vol-43-no-3.16507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
BACKGROUND One of the major factors restricting in vivo efficacy of dendritic cells (DCs) based immunotherapy is the inefficient migration of these cells to the lymphoid tissue, wherein DCs activate antigen-specific T cells. A fundamentally new approach for the possibility of enhancing the antitumor effects of DC-based immunotherapy may be the use of magnetically sensitive nanocomplexes to increase the target delivery of DCs to the lymph nodes of the recipient. AIM To study the antitumor and immunomodulatory effects of the DC-nanovaccine with magnetosensitive properties and its influence on the immunosuppressive tumor microenvironment in mice with sarcoma 37. MATERIALS AND METHODS The antitumor, antimetastatic and immunomodulatory effects of DCs loaded with magnetic nanocomplex under magnetic field (MF) control in mice with sarcoma 37 have been investigated. RESULTS Combined therapy contributed to a significant reduction in tumor volume and weight compared to the control group of mice and mice that received the DC vaccine without MF. Therapy with magnetically sensitive DC nanovaccine with and without the addition of the MF was accompanied by a significant down-regulation of the level of FoxP3, transforming growth factor β, interleukin (IL)-10 and vascular endothelial growth factors, mRNA expression in tumor tissues. A significant increase in interferon-γ and IL-4 mRNA expression was found in mice treated with the magnetically sensitive DC nanovaccine under MF control. CONCLUSION A significant increase in the antitumor efficacy of the DC vaccine can be achieved using magnetosensitive nanocarriers of tumor antigens under MF control.
Collapse
Affiliation(s)
- N Khranovska
- National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| | - O Skachkova
- National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| | - O Gorbach
- National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| | - M Inomistova
- National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| | - V Orel
- National Cancer Institute of Ukraine, Kyiv 03022, Ukraine
| |
Collapse
|
6
|
Gorodetska I, Inomistova M, Khranovska N, Skachkova O, Michailovich Y, Rybchenko L, Bychkova A, Stefanovich A, Klimuk B, Poluben L, Klymenko S, Rossokha Z, Kyriachenko S, Popova O, Gorovenko N, Ponomarova O, Serga S, Kozeretska I. The reduction of two BRCA1 gene mutations frequencies in ovarian cancer patients from Ukraine. Meta Gene 2021. [DOI: 10.1016/j.mgene.2021.100900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
7
|
Zborovskii YL, Orysyk VV, Golovynska I, Dzhus OI, Garmanchuk LV, Stepanov YV, Khranovska N, Nehelia AO, Golovynskyi S, Ohulchanskyy TY, Qu J, Orysyk SI, Pekhnyo VI, Vovk MV. Novel Hybrid Compound 4-[(E)-2-phenylethenesulfonamido]-N-hydroxybutanamide with Antimetastatic and Cytotoxic Action: Synthesis and Anticancer Screening. Anticancer Agents Med Chem 2019. [PMID: 29532761 DOI: 10.2174/1871520618666180313151503] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
BACKGROUND One of the most promising strategies to develop multi-targeted anticancer therapeutics is to introduce to the structure of a potential drug two or more pharmacophores (functional groups or structural fragments), which have antiproliferative, proapoptotic or antimetastatic properties acting via different mechanisms. OBJECTIVE To design, synthesize and perform screening of a novel hybrid anticancer compound. METHOD A novel hybrid compound 4-[(E)-2-phenylethenesulfonamido]-N-hydroxybutanamide, combining butanehydroxamate and styrenesulfonamide moieties, was designed, synthesized and investigated as a potent antimetastatic and antiproliferative agent. The structure and purity of the synthesized compound were confirmed by 1H NMR, 13C NMR, LC/MS spectroscopy and elemental analysis. The compound was screened for the anticancer activity in vitro against HeLa and in vivo against Lewis lung carcinoma tumor, using an antitumor metalloenzyme inhibitor GM6001 (Ilomastat, Galardin) and Pifithrin-μ as control anticancer agents. RESULTS It was found that the application of our compound resulted in a high fraction of apoptotic cells in the cell population, along with disruption in the cell cycle profile manifested as arrest of proliferative phases. Furthermore, changes of the morphological properties (i.e., an enhancement of adhesive properties and reduction of the nuclear-to-cytoplasm ratio) were found. The in vivo screening revealed that the compound significantly inhibited the metastasizing process that was manifested by a reduction in the number and volume of metastases. CONCLUSIONS The obtained results demonstrate that our compound can serve as a base for further structure optimization in order to design new highly-effective antimetastatic and antitumor agents.
Collapse
Affiliation(s)
- Yurii L Zborovskii
- Institute of Organic Chemistry, NAS of Ukraine, 5 Murmanska St., 02660, Kyiv, Ukraine
| | - Viktor V Orysyk
- Institute of Organic Chemistry, NAS of Ukraine, 5 Murmanska St., 02660, Kyiv, Ukraine
| | - Iuliia Golovynska
- Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, 518060, Shenzhen, China
| | - Olena I Dzhus
- Taras Shevchenko National University of Kyiv, ESC "Institute of Biology and Medicine", 64 Volodymyrska St., 01601, Kyiv, Ukraine
| | - Liudmyla V Garmanchuk
- Taras Shevchenko National University of Kyiv, ESC "Institute of Biology and Medicine", 64 Volodymyrska St., 01601, Kyiv, Ukraine
| | - Yurii V Stepanov
- Taras Shevchenko National University of Kyiv, ESC "Institute of Biology and Medicine", 64 Volodymyrska St., 01601, Kyiv, Ukraine
| | | | - Anatolii O Nehelia
- Taras Shevchenko National University of Kyiv, ESC "Institute of Biology and Medicine", 64 Volodymyrska St., 01601, Kyiv, Ukraine
| | - Sergii Golovynskyi
- Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, 518060, Shenzhen, China
| | - Tymish Y Ohulchanskyy
- Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, 518060, Shenzhen, China
| | - Junle Qu
- Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, 518060, Shenzhen, China
| | - Svitlana I Orysyk
- V.I. Vernadskii Institute of General and Inorganic Chemistry, NAS of Ukraine, 32/34 Palladina Ave., 03680, Kyiv, Ukraine
| | - Vasyl I Pekhnyo
- V.I. Vernadskii Institute of General and Inorganic Chemistry, NAS of Ukraine, 32/34 Palladina Ave., 03680, Kyiv, Ukraine
| | - Myhaylo V Vovk
- Institute of Organic Chemistry, NAS of Ukraine, 5 Murmanska St., 02660, Kyiv, Ukraine
| |
Collapse
|
8
|
Askolskyi A, Syvak L, Zharinov O, Khranovska N. Predicting the occurrence and prevention of early anthracycline cardiotoxicity of chemotherapy in patients with breast cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy300.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Novosad O, Pastushenko I, Skrypets T, Tytorenko I, Kadnikova T, Skachkova O, Gorbach O, Svergun N, Khranovska N, Kriachok I. Impact of genetic polymorphisms on prognosis and survival of diffuse large B-cell lymphoma. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy286.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
Gorbach O, Khranovska N, Skachkova O, Inomistova M, Shumeiko I, Orel V. Strategy to improve the antitumor efficacy of dendritic cell-based nanovaccine under magnetic field control. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy303.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
Garmanchuk L, Pavluk O, Anatoliy N, Khranovska N. Condition medium of T cells increased apoptosis and decreased proliferation properties of MCF-7 cells in 3D culture. Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30634-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
12
|
Inomistova M, Khranovska N, Skachkova O, Gorbach O, Shumeiko I, Orel V. Antitumor effect of dendritic cells loaded with Fe2O3 magnetic nanocomplex in mice with sarcoma 37. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy047.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Inomistova M, Khranovska N, Skachkova O, Klymniuk G, Pavlyk S. Alteration of p53 mRNA expression in neuroblastoma and its impact in disease outcome. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx391.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
14
|
Inomistova M, Khranovska N, Skachkova O, Makeenko O, Orel V. Approach based on magnetic nanocomplexes improves antitumor efficacy of dendritic cells immunotherapy in mice. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx361.067] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
15
|
Skrypets T, Novosad O, Pastushenko Y, Skachkova O, Gorbach O, Khranovska N, Kryachok I. Evaluation of indoleamine 2,3-dioxygenase expression (IDO), transforming growth factor beta (TGF-β) and interleukin 13 (IL13) expression on clinical outcome in patients with Hodgkin’s lymphoma. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx373.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
16
|
Khranovska N, Skachkova O, Sydor R, Inomistova M, Sovenko V, Kondratsky Y. PUB136 Effect of PD-L1 Tumor Expression on Clinical Benefit of Personalized Dendritic Cell Based Vaccine in Patients with Non-Small Cell Lung Cancer. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2016.11.2107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
17
|
Inomistova M, Khranovska N, Skachkova O, Sydor R. Immunological markers of DC-based vaccine antitumor efficacy in patients with NSCLC. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw525.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
18
|
Kryachok I, Skrypets T, Novosad O, Khranovska N, Skachkova O, Ulianchenko K, Martynchyk A, Tytorenko I, Filonenko K, Stepanishyna I, Svergun N, Gorbach O, Nevdakh O. The role of indoleamine 2,3-dioxygenase expression in diffuse large B-cell lymphoma prognosis. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw375.17] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Inomistova M, Khranovska N, Skachkova O, Klymnyuk G, Svergun N, Adamchuk N. p53-associated microRNAs and MDM2 expression in the biology and prognosis of neuroblastoma. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61025-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
20
|
Inomistova M, Khranovska N, Svergun N, Klymniuk G, Skachkova O. 151 Prognostic significance of microRNA-137 expression alterations in neuroblastoma. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30049-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Gorbach O, Khranovska N, Skachkova O, Sydor R, Svergun N, Pozur V. Low Doses of Cisplatin can Help Dendritic Cell Vaccines to Reduce Immunosuppression in Tumor Microenvironment. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu467.5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
22
|
Svergun N, Khranovska N, Kriachok I, Novosad O, Kadnikova T, Gorbach O, Tytorenko I, Pastushenko I, Kushchevyy E, Ulianchenko K. The Role of Microenvironment Expression of Pd-1 Ligands and Chemokines in Clinical Outcome of Hodgkin'S Lymphoma. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu339.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
23
|
Gorbach O, Khranovska N, Skachkova O, Sydor R, Svergun N, Pozur V. The Combination of Antitumor Vaccine and Low Doses of Doxorubicin As an Effective Method Against Tumor Immunosuppression. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu358.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
24
|
Gerashchenko O, Zhuravel E, Skachkova O, Khranovska N, Pushkarev V, Pogrebnoy P, Soldatkina M. Involvement of human beta-defensin-2 in regulation of malignant potential of cultured human melanoma cells. Exp Oncol 2014; 36:17-23. [PMID: 24691279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
BACKGROUND AND AIM Human beta-defensin-2 (hBD-2) is an antimicrobial cationic peptide capable to control human carcinoma cell growth via cell cycle regulation. The present study was aimed on determination of hBD-2 influence on the growth patterns and malignant potential of cultured human melanoma cells. METHODS The study was performed on cultured human melanoma cells of mel Z and mel Is lines treated with recombinant hBD-2 (rec-hBD-2); cell viability, proliferation, cell cycle distribution, and anchorage-independent growth were analyzed using MTT test, direct cell counting, flow cytometry, and colony forming assay respectively. Expression and/or phosphorylation levels of proteins involved in cell cycle control were evaluated by Western blotting. RESULTS The treatment of mel Z and mel Is cells with rec-hBD-2 in a concentration range of 100-1000 nM resulted in a concentration-dependent suppression of cell proliferation, viability, and colony forming activity. It has been shown that rec-hBD-2 exerts its growth suppression effects via significant downregulation of B-Raf expression, activation of pRB and upregulation of p21(WAF1) expression, downregulation of cyclin D1 and cyclin E resulting in cell cycle arrest at G1/S checkpoint. CONCLUSION According to obtained results, hBD-2 exerts its growth suppression effect toward human melanoma cells via downregulation of B-Raf, cyclin D1 and cyclin E expression, upregulation of p21(WAF1) expression and activation of pRB.
Collapse
Affiliation(s)
- O Gerashchenko
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine
| | - E Zhuravel
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine
| | - O Skachkova
- National Cancer Institute MPH of Ukraine, Kyiv 03022, Ukraine
| | - N Khranovska
- National Cancer Institute MPH of Ukraine, Kyiv 03022, Ukraine
| | - V Pushkarev
- Institute of Endocrinology and Metabolism, AMS of Ukraine, Kyiv, Ukraine
| | - P Pogrebnoy
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine
| | - M Soldatkina
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine
| |
Collapse
|
25
|
Shchepotin I, Kolesnik O, Lukashenko A, Khranovska N, Khvorostovskyy R. Adjuvant Chemotherapy in Combined Treatment of the Colorectal Liver Metastases. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt203.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
26
|
Khranovska N, Potebnia G, Skachkova O, Tanasienko O, Svergun N, Sitko V, Fedorchuk O, Niculina V. Novel Strategy for Designing and Optimizing of Dendritic – Cell – Based Anticancer Vaccine. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)34217-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
27
|
Khranovska N, Klymnyuk G, Shaida O, Svergun N. 4116 Fusion genes PAX3/7-FKHR as molecular markers of bone marrow micrometastasis in paediatric alveolar rhabdomyosarcoma. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)70769-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
28
|
Sovenko V, Khranovska N, Ganul V, Shvets Y, Ganul A, Sitko V, Skachkova O, Zemskov S, Grinevich Y. 9057 New dendritic cell immunotherapy approach: randomized phase II study in IIB-IIIA stage non-small cell lung cancer patients. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71770-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
29
|
Khranovska N, Klymnyuk G, Ionkina N, Karacharova I, Balitska O, Shaida E. Informative comprehension of detection of chimeric genes PAX3/ 7-FKHR in prognostically unfavourable forms of rhabdomiosarcomas in children. EJC Suppl 2008. [DOI: 10.1016/s1359-6349(08)71786-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|